Pages that link to "Q43939085"

The following pages link to Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens (Q43939085):

Displaying 12 items.

• Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB (Q24201325) (← links)
• Advances in the diagnosis and treatment of tuberculosis. (Q30353049) (← links)
• Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer (Q33650105) (← links)
• Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa. (Q33924806) (← links)
• Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
• Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru (Q34554997) (← links)
• Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study (Q34974157) (← links)
• Initiating antiretrovirals during tuberculosis treatment: a drug safety review (Q35043048) (← links)
• Community-Based Rapid Oral Human Immunodeficiency Virus Testing for Tuberculosis Patients in Lima, Peru (Q36213203) (← links)
• Tuberculosis and HIV: Implications in the developing world (Q36592768) (← links)
• New antituberculous drugs in development (Q37766119) (← links)
• Global access of rifabutin for the treatment of tuberculosis - why should we prioritize this? (Q91984625) (← links)